Mirion Technologies (NYSE:MIR) Sets New 52-Week Low – Should You Sell?

Mirion Technologies, Inc. (NYSE:MIR)’s share price reached a new 52-week low during trading on Wednesday. The company traded as low as $14.08 and last traded at $14.3450, with a volume of 194176 shares traded. The stock had previously closed at $14.34.

Analysts Set New Price Targets

MIR has been the topic of a number of recent research reports. Jefferies Financial Group started coverage on shares of Mirion Technologies in a report on Thursday, September 3rd. They issued a “buy” rating and a $20.00 target price on the stock. Citigroup lowered their price target on shares of Mirion Technologies from $28.00 to $24.00 and set a “buy” rating for the company in a report on Thursday, July 30th. Morgan Stanley cut their price objective on shares of Mirion Technologies from $27.00 to $25.00 and set an “equal weight” rating for the company in a research report on Monday, July 13th. B. Riley Financial reduced their price objective on shares of Mirion Technologies from $29.00 to $27.00 and set a “buy” rating on the stock in a research note on Thursday, July 30th. Finally, The Goldman Sachs Group restated a “buy” rating and set a $23.00 target price on shares of Mirion Technologies in a research report on Wednesday, July 29th. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $25.12.

Mirion Technologies Trading Up 1.5%

The business has a 50 day simple moving average of $15.68 and a 200-day simple moving average of $17.34. The company has a current ratio of 3.20, a quick ratio of 2.63 and a debt-to-equity ratio of 0.64. The stock has a market capitalization of $3.62 billion, a price-to-earnings ratio of 145.60 and a beta of 1.05.

Mirion Technologies (NYSE:MIR) last posted its quarterly earnings data on Tuesday, July 28th. The company reported $0.12 EPS for the quarter, beating analysts’ consensus estimates of $0.10 by $0.02. The company had revenue of $266.80 million during the quarter, compared to the consensus estimate of $269.32 million. Mirion Technologies had a net margin of 2.39% and a return on equity of 6.59%. The company’s quarterly revenue was up 19.7% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.11 EPS. Mirion Technologies has set its FY 2026 guidance at 0.480-0.550 EPS. On average, equities analysts predict that Mirion Technologies, Inc. will post 0.55 earnings per share for the current year.

Hedge Funds Weigh In On Mirion Technologies

A number of large investors have recently bought and sold shares of the stock. Rockefeller Capital Management L.P. grew its holdings in shares of Mirion Technologies by 17.2% during the 4th quarter. Rockefeller Capital Management L.P. now owns 1,139,037 shares of the company’s stock worth $26,676,000 after purchasing an additional 167,454 shares during the period. Madison Asset Management LLC acquired a new position in Mirion Technologies during the second quarter valued at approximately $3,407,000. Goldman Sachs Group Inc. lifted its position in Mirion Technologies by 3.8% during the fourth quarter. Goldman Sachs Group Inc. now owns 5,248,506 shares of the company’s stock valued at $122,920,000 after buying an additional 193,914 shares in the last quarter. Lazard Asset Management LLC grew its stake in Mirion Technologies by 125.4% during the first quarter. Lazard Asset Management LLC now owns 322,421 shares of the company’s stock worth $5,994,000 after buying an additional 179,358 shares during the period. Finally, B. Metzler seel. Sohn & Co. AG purchased a new stake in Mirion Technologies during the second quarter worth approximately $2,597,000. Hedge funds and other institutional investors own 78.51% of the company’s stock.

About Mirion Technologies

Mirion Technologies, Inc develops and provides radiation detection, measurement, and analysis solutions. Its products and services are used to monitor radiation, support nuclear safety, improve operational efficiency, and provide data for medical, industrial, scientific, and government applications.

The company’s offerings include radiation detectors, spectroscopy systems, dosimetry and personnel-monitoring solutions, radiation-monitoring equipment, and related software and services. In healthcare, Mirion provides technologies used in radiation therapy quality assurance, medical imaging, and radiation safety.